CN113816993B - Synthesis method of beta-cyanophosphonate derivative - Google Patents

Synthesis method of beta-cyanophosphonate derivative Download PDF

Info

Publication number
CN113816993B
CN113816993B CN202110357640.8A CN202110357640A CN113816993B CN 113816993 B CN113816993 B CN 113816993B CN 202110357640 A CN202110357640 A CN 202110357640A CN 113816993 B CN113816993 B CN 113816993B
Authority
CN
China
Prior art keywords
reaction
ionic liquid
stirring
diazabicyclo
ethyl acetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN202110357640.8A
Other languages
Chinese (zh)
Other versions
CN113816993A (en
Inventor
徐大振
周坚
佟淼
胡欣
李向赛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nankai University
Original Assignee
Nankai University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nankai University filed Critical Nankai University
Priority to CN202110357640.8A priority Critical patent/CN113816993B/en
Publication of CN113816993A publication Critical patent/CN113816993A/en
Application granted granted Critical
Publication of CN113816993B publication Critical patent/CN113816993B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/54Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention discloses a synthesis method of a derivative containing beta-cyano phosphonate, which comprises the following steps: under the catalysis of DABCO-based ionic liquid, aromatic aldehyde, malononitrile, phosphite ester and ketene compound are heated and reacted mildly in a solvent to prepare the derivative containing beta-cyano phosphonate. The synthetic method disclosed by the invention has the advantages of simple steps, short reaction time, high reaction yield, low price and easiness in obtaining of the used ionic liquid catalyst, wide application range of the substrate of the synthetic method disclosed by the invention, and the most important oxindole compounds with multiple functional group phosphonate groups can be obtained by a four-component one-pot method, so that the method is a high-efficiency four-component reaction.

Description

Synthesis method of beta-cyanophosphonate derivative
Technical Field
The invention belongs to the technical field of organic synthesis, and particularly relates to a synthesis method of derivatives containing beta-cyanophosphonate derivatives.
Background
Beta-cyanophosphonate derivatives are a very important class of compounds, which are important skeletons of many natural products and bioactive compounds, and the abundant diversity structure of the derivatives and the broad spectrum of biological activity thereof make the compounds extremely in need of efficient synthetic methods. In the synthesis system, the constructed carbon four-center is still a difficulty in the current organic synthesis chemistry, and the derivatives containing the beta-cyanophosphonate derivatives are not reported at present.
Disclosure of Invention
Aiming at the defects of the prior art, the invention aims to provide a synthetic method of derivatives containing beta-cyanophosphonate derivatives, the synthetic method is simple and convenient to operate, short in reaction time, low in production cost, less in reaction green pollution, simple in post-treatment and low in cost, and the ionic liquid catalyst used in the synthetic method is a cheap, easily-obtained and environment-friendly efficient catalyst.
The purpose of the invention is realized by the following technical scheme.
A synthetic method of a derivative containing beta-cyanophosphonate comprises the following steps: stirring a reactant, malononitrile, phosphite ester, an ketene compound, an ionic liquid catalyst and a solvent for reaction, extracting, drying, filtering, evaporating and separating by a chromatographic column to obtain the derivative containing beta-cyanophosphonate, wherein the ratio of the reactant, the malononitrile, the phosphite ester, the ketene compound and the ionic liquid catalyst is (1-1.5): (1-1.5): (1-1.5): (0.1-0.2), wherein the ionic liquid catalyst is 1, 4-diazabicyclo [2.2.2] octane acetate, 1, 4-diazabicyclo [2.2.2] octane bromate, 1, 4-diazabicyclo [2.2.2] octane hydrogen sulfate, 1, 4-diazabicyclo [2.2.2] octane hydrochloride or 1, 4-diazabicyclo [2.2.2] octane tetrafluoroborate.
In the above-mentioned technical scheme, 1, 4-diazabicyclo [2.2.2]The structural formula of octane acetate is
Figure BDA0003004113810000011
1, 4-diazabicyclo [2.2.2]The structural formula of octane bromate is shown in the specification
Figure BDA0003004113810000021
1, 4-diazabicyclo [2.2.2]The structural formula of the octyl hydrogen sulfate is shown in the specification
Figure BDA0003004113810000022
1, 4-diazabicyclo [2.2.2]The structural formula of octane hydrochloride is
Figure BDA0003004113810000023
1, 4-diazabicyclo [2.2.2]The structural formula of octane tetrafluoroborate is shown in the specification
Figure BDA0003004113810000024
In the technical scheme, the solvent is one or a mixture of more of toluene, ethanol, n-hexane, tetrahydrofuran and methanol.
In the technical scheme, the stirring reaction is a reaction at 20-60 ℃.
In the technical scheme, the reactant is
Figure BDA0003004113810000025
Wherein, R is1Is CH3CN or Br.
In the above technical scheme, the phosphite ester is
Figure BDA0003004113810000026
Wherein, R is2Me, Et or Ph.
In the above technical solution, the ratio of the parts by weight of the substance of the reactant to the parts by volume of the solvent is 1: (0.5-1), wherein the unit of the parts by weight of the substances is mmol, and the unit of the parts by volume is mL.
In the above technical scheme, the time for the stirring reaction to proceed is detected by thin layer chromatography.
In the technical scheme, the stirring reaction time is at least 20min, and preferably 150-210 min.
In the technical scheme, the reactant, the malononitrile, the phosphite ester, the ionic liquid catalyst and the solvent are stirred for 30-60 min at 40-50 ℃, and then the ketene compound is added for the stirring reaction.
In the technical scheme, the extraction is to add water and then add ethyl acetate for washing.
In the technical scheme, anhydrous sodium sulfate is adopted for drying.
In the technical scheme, an eluent for the chromatographic reaction is a mixture of petroleum ether and ethyl acetate, and the ratio of the petroleum ether to the ethyl acetate is (1-3): 1 in parts by volume.
The synthetic method disclosed by the invention has the advantages of simple steps, short reaction time, high reaction yield, low price and easiness in obtaining of the used ionic liquid catalyst, and in addition, the substrate application range of the synthetic method disclosed by the invention is wide, and the extremely important multifunctional group beta-cyanophosphonate derivatives can be obtained through a four-component one-pot method.
Detailed Description
The technical scheme of the invention is further explained by combining specific examples.
In the specific implementation mode of the invention, the reagents and medicines involved in the synthesis are purchased from Tianjin reagent six factories in commercial way, the purity of the medicines is analytically pure, and the reagents and the medicines are directly used without any pretreatment.
The synthesis method of the invention continuously stirs in the whole process, and the model of an electromagnetic heating stirrer used for stirring is NUOVAII (Temaran, USA); the rotary evaporator was model RE-2000A (Otsuwa instruments liability Co., Ltd., Otsu). Nuclear magnetic resonance instrument model: bruker AV-400 spectrometer, 400MHz, DMSO-d 6. In a particular embodiment of the invention, parts by weight of a substance are in mmol units and parts by volume are in ml units. Filtering through a glass sand core funnel (model: G120-30 um).
The extent of reaction progress was checked by Thin Layer Chromatography (TLC). In thin layer chromatography, silica gel plate type G254 with size of 15mm × 50mm is used; the polarity of the developing solvent is a mixture of ethyl acetate and petroleum ether, and the volume ratio of the ethyl acetate to the petroleum ether is 1: 2. The detection process uses a ZF-I type three-purpose ultraviolet analyzer (Shanghai Ching Tang), the used medicines are purchased from Tianjin reagent six factories, the purity of the medicines is analytical purity, all medicines are directly used, and no pretreatment is carried out. When the increase of the product is not found by TLC monitoring, the synthesis method of the invention is marked to be finished, and the next separation operation can be continued.
Example 1
Figure BDA0003004113810000031
A synthetic method of a derivative containing beta-cyanophosphonate comprises the following steps: 1.0mmol (0.120g) of p-tolualdehyde, 1.0mmol (0.066g) of malononitrile, 1.0mmol (0.138g) of diethyl phosphite and 0.2mmol of an ionic liquid catalyst 1, 4-diazabicyclo [2.2.2] in that order]Adding octane acetate into 10ml dry round bottom flask, adding 1ml THF (tetrahydrofuran) as solvent, heating at 40 deg.C and stirring for reaction for 30min, and adding 1.0mmol (0.084g) 1-pentaneAlkene-3-ketone, stirring at 40 ℃ for reaction, monitoring the stirring reaction time (2h) by TLC, adding 10ml of water after the reaction is finished, cooling, adding 10ml of ethyl acetate for extraction for 3 times, drying the organic phase by anhydrous sodium sulfate, filtering and distilling off, separating and purifying the crude product by column chromatography, adopting petroleum ether and ethyl acetate as eluent (the ratio of the petroleum ether to the ethyl acetate is 3:1 in parts by volume), distilling off the eluent and drying to obtain the pure derivative (molecular formula C) containing beta-cyanophosphonate20H27N2O4P)0.183g, purity greater than 98% and reaction yield 47%.
1H NMR(400MHz,CDCl3):δ=1.06(t,J=7.2Hz,3H,CH3),1.15(t,J=7.2Hz,3H,CH3),1.34(t,J=7.2Hz,3H,CH3),2.27-2.32(m,1H,CH2),2.36(s,3H,CH3),2.43-2.51(m,3H,CH2),2.83(t,J=7.2Hz,2H,CH2),3.42(s,0.5H,CH),3.48(s,0.5H,CH),3.81-3.88(m,1H,CH2),4.03-4.09(m,1H,CH2),4.12-4.20(m,2H,CH2),7.22(d,J=7.8Hz,1H,ArH),7.43(s,1H,ArH).
13C NMR(100MHz,CDCl3):δ=7.6,16.1,21.2,31.7,36.1,38.0,39.3,48.9(d,JCP=187.6Hz,C-P),63.1,64.1,114.1,114.2,114.4,127.1,129.9,130.2,139.5,207.4.
31P NMR(162MHz,CDCl3):δ=18.40.
Example 2
Figure BDA0003004113810000041
A synthetic method of a derivative containing beta-cyanophosphonate comprises the following steps: 1.0mmol (0.131g) of p-cyanobenzaldehyde, 1.0mmol (0.066g) of malononitrile, 1.0mmol (0.138g) of diethyl phosphite and 0.2mmol of an ionic liquid catalyst 1, 4-diazabicyclo [2.2.2] in that order]Adding octane acetate into 10ml dry round-bottom flask, adding 1ml THF as solvent, heating and stirring at 40 deg.C for 30min, adding 1.0mmol (0.084g) 1-penten-3-one, stirring at 40 deg.C for reaction, and allowing reaction to pass through TLC monitors the stirring reaction time (2h), after the reaction is finished, 10ml of water is added, after cooling, 10ml of ethyl acetate is added for extraction for 3 times, the organic phase is dried by anhydrous sodium sulfate, filtered and evaporated, the crude product is separated and purified by column chromatography, petroleum ether and ethyl acetate are used as eluent (the ratio of the petroleum ether to the ethyl acetate is 3:1 according to the volume portion), and the eluent is evaporated and dried to obtain the pure derivative (the molecular formula C) containing the beta-cyanophosphonate20H24N3O4P)0.220g, purity greater than 98% and reaction yield 55%.
1H NMR(400MHz,CDCl3):δ=0.97(t,J=7.2Hz,3H,CH3),1.11(t,J=6.8Hz,3H,CH3),1.24(t,J=7.2Hz,3H,CH3),2.16-2.24(m,1H,CH2),2.39-2.44(m,2H,CH2),2.46-2.54(m,1H,CH2),2.72-2.79(m,2H,CH2),3.60(s,0.5H,CH),3.66(s,0.5H,CH),3.86-3.92(m,1H,CH2),3.98-4.14(m,3H,CH2),7.65(s,4H,ArH).
13C NMR(100MHz,CDCl3):δ=7.6,16.0,16.1,16.2,31.6,36.1,38.0,39.0,48.7(d,JCP=141.0Hz,C-P),63.7,64.4,113.4,113.7,113.8,113.9,118.0,131.1,132.8,136.2,207.4.
31P NMR(162MHz,CDCl3):δ=16.84.
Example 3
Figure BDA0003004113810000051
A synthetic method of a derivative containing beta-cyanophosphonate comprises the following steps: 1.0mmol (0.185g) of p-bromobenzaldehyde, 1.0mmol (0.066g) of malononitrile, 1.0mmol (0.138g) of diethyl phosphite and 0.2mmol of an ionic liquid catalyst 1, 4-diazabicyclo [2.2.2] in that order]Adding octane acetate into 10ml dry round-bottom flask, adding 1ml THF as solvent, heating and stirring at 50 deg.C for reaction for 30min, adding 1.0mmol (0.084g) 1-penten-3-one, stirring at 50 deg.C for reaction, monitoring stirring reaction time by TLC (2 hr), adding 10ml water after reaction, cooling, addingExtracting with 10ml ethyl acetate for 3 times, drying the organic phase with anhydrous sodium sulfate, filtering, distilling off, separating and purifying the crude product by column chromatography, eluting with petroleum ether and ethyl acetate (the ratio of petroleum ether to ethyl acetate is 3:1) by volume, distilling off the eluent, and drying to obtain the pure derivative (molecular formula C) containing beta-cyanophosphonate19H24BrN2O4P)0.336g, purity greater than 98%, reaction yield 74%.
1H NMR(400MHz,CDCl3):δ=1.07(t,J=7.8Hz,3H,CH3),1.88(t,J=7.2Hz,3H,CH3),1.35(t,J=7.2Hz,3H,CH3),2.24-2.32(m,1H,CH2),2.47-2.52(m,3H,CH2),2.82-2.86(m,2H,CH2),3.44(s,0.5H,CH),4.00(s,0.5H,CH),3.88-3.94(m,1H,CH2),4.08-4.10(m,1H,CH2),4.15-4.21(m,2H,CH2),7.44(d,J=6.8Hz,1H,ArH),7.57(d,J=8.4Hz,1H,ArH).
13C NMR(100MHz,CDCl3):δ=7.6,16.1,31.6,36.0,38.0,39.1,48.3,49.7,63.4(d,JCP=87.6Hz,C-P),113.9,114.0,114.1,123.9,129.6,131.9,132.4,207.3.
31P NMR(162MHz,CDCl3):δ=17.61.
Example 4
Figure BDA0003004113810000052
A synthetic method of a derivative containing beta-cyanophosphonate comprises the following steps: 1.0mmol (0.185g) of m-bromobenzaldehyde, 1.0mmol (0.066g) of malononitrile, 1.0mmol (0.138g) of diethyl phosphite and 0.2mmol of the ionic liquid catalyst 1, 4-diazabicyclo [2.2.2] in that order]Adding octane acetate into a 10ml dry round-bottom flask, adding 1ml THF as a solvent, heating and stirring at 40 ℃ for reaction for 30min, adding 1.0mmol (0.084g) of 1-penten-3-one, stirring at 40 ℃ for reaction, monitoring the stirring reaction time by TLC (thin layer chromatography) for 2h), adding 10ml water after the reaction is finished, cooling, adding 10ml ethyl acetate for extraction for 3 times, drying an organic phase by anhydrous sodium sulfate, and then performing stirring reaction on the organic phase for 2hFiltering, evaporating, purifying the crude product by column chromatography, eluting with petroleum ether and ethyl acetate (the ratio of petroleum ether to ethyl acetate is 3:1), evaporating, eluting, and drying to obtain pure derivative (molecular formula C) containing beta-cyanophosphonate19H24BrN2O4P)0.286g, purity greater than 98% and reaction yield 63%.
1H NMR(400MHz,CDCl3):δ=0.98(t,J=7.2Hz,3H,CH3),1.11(t,J=7.2Hz,3H,CH3),1.27(t,J=6.8Hz,3H,CH3),2.18-2.24(m,1H,CH2),2.39-2.49(m,3H,CH2),2.72-2.79(m,2H,CH2),3.43(s,0.5H,CH),3.49(s,0.5H,CH),3.83-3.90(m,1H,CH2),4.01-4.13(m,3H,CH2),7.24(t,J=8.0Hz,1H,ArH),7.48(d,J=7.6Hz,1H,ArH),7.61(s,1H,ArH).
13C NMR(100MHz,CDCl3):δ=7.6,16.1,31.7,36.1,38.0,39.0,48.8(d,JCP=141.5Hz,C-P),63.8,64.5,113.5,113.6,113.8,113.8,117.9,131.1,132.9,136.1,207.4.
31P NMR(162MHz,CDCl3):δ=16.89.
Example 5
Figure BDA0003004113810000061
A synthetic method of a derivative containing beta-cyanophosphonate comprises the following steps: 1.0mmol (0.185g) of o-bromobenzaldehyde, 1.0mmol (0.066g) of malononitrile, 1.0mmol (0.138g) of diethyl phosphite and 0.2mmol of an ionic liquid catalyst 1, 4-diazabicyclo [2.2.2] in this order]Adding octane acetate into 10ml of dry round-bottom flask, adding 1ml of THF as solvent, heating and stirring at 40 ℃ for reaction for 30min, adding 1.0mmol (0.084g) of 1-penten-3-one, stirring at 40 ℃ for reaction, monitoring the stirring reaction time (2h) by TLC (thin layer chromatography), adding 10ml of water after the reaction is finished, cooling, adding 10ml of ethyl acetate for extraction for 3 times, drying an organic phase with anhydrous sodium sulfate, filtering and distilling off, separating and purifying a crude product by column chromatography, and adopting petroleum ether and acetic acidEthyl ester is used as eluent (the ratio of petroleum ether to ethyl acetate is 3:1 according to the volume portion), and pure derivative (molecular formula C) containing beta-cyano phosphonate is obtained after evaporation, eluent and drying19H24BrN2O4P)0.322g, purity greater than 98% and reaction yield 71%.
1H NMR(400MHz,CDCl3):δ=1.07(t,J=7.2Hz,3H,CH3),1.16(t,J=7.2Hz,3H,CH3),1.37(t,J=7.2Hz,3H,CH3),2.22-2.30(m,1H,CH2),2.47-2.52(m,2H,CH2),2.55-2.63(m,2H,CH2),2.80-2.92(m,1H,CH2),3.87-3.94(m,1H,CH2),4.04-4.13(m,2H,CH2),4.18-4.28(m,2H,CH2),4.38(s,0.5H,CH),4.43(s,0.5H,CH),7.27-7.31(m,1H,ArH),7.44(t,J=8.0Hz,1H,ArH),7.69(d,J=8.0Hz,1H,ArH),8.03(d,J=8.0Hz,1H,ArH).
13C NMR(100MHz,CDCl3):δ=7.5,15.9,16.1,31.4,35.9,37.7,38.9,46.1,47.5,63.4(d,JCP=68.4Hz,C-P),113.5,113.6,114.0,126.8,128.3,130.4,130.9,133.6,207.0.
31P NMR(162MHz,CDCl3):δ=17.40.
Example 6
Figure BDA0003004113810000071
A synthetic method of a derivative containing beta-cyanophosphonate comprises the following steps: 1.0mmol (0.175g) of 3, 4-dichlorobenzaldehyde, 1.0mmol (0.066g) of malononitrile, 1.0mmol (0.138g) of diethyl phosphite and 0.2mmol of an ionic liquid catalyst 1, 4-diazabicyclo [2.2.2] in that order]Adding octane acetate into a 10ml dry round-bottom flask, adding 1ml THF as a solvent, heating and stirring at 40 ℃ for reaction for 30min, adding 1.0mmol (0.084g) of 1-penten-3-one, stirring at 40 ℃ for reaction, monitoring the stirring reaction time (3h) by TLC (thin layer chromatography), adding 10ml water after the reaction is finished, cooling, adding 10ml ethyl acetate for extraction for 3 times, drying an organic phase by anhydrous sodium sulfate, filtering and distilling off, and purifying a crude product by column chromatography separationPetroleum ether and ethyl acetate are used as eluent (the ratio of the petroleum ether to the ethyl acetate is 3:1 in parts by volume), and the eluent is evaporated and dried to obtain the pure derivative (molecular formula C) containing the beta-cyano phosphonate ester19H23Cl2N2O4P)0.320g, purity greater than 98% and reaction yield 72%.
1H NMR(400MHz,CDCl3):δ=1.08(t,J=7.2Hz,3H,CH3),1.24(t,J=7.2Hz,3H,CH3),1.36(t,J=6.8Hz,3H,CH3),2.25-2.32(m,1H,CH2),2.48-2.58(m,3H,CH2),2.83-2.88(m,2H,CH2),3.45(s,0.5H,CH),3.50(s,0.5H,CH),3.96-4.03(m,1H,CH2),4.11-4.22(m,3H,CH2),7.45(d,J=7.2Hz,1H,ArH),7.53(d,J=8.4Hz,1H,ArH),7.64(s,1H,ArH).
13C NMR(100MHz,CDCl3):δ=7.6,16.2,31.7,36.1,38.0,39.1,48.3(d,JCP=141.7Hz,C-P),63.6,64.4,113.7,113.8,113.9,129.4,130.8,131.2,132.2,133.5,134.1,207.2.
31P NMR(162MHz,CDCl3):δ=17.05.
Example 7
Figure BDA0003004113810000081
A synthetic method of a derivative containing beta-cyanophosphonate comprises the following steps: 1.0mmol (0.112g) of 2-thiophenecarboxaldehyde, 1.0mmol (0.066g) of malononitrile, 1.0mmol (0.138g) of diethyl phosphite, and 0.2mmol of an ionic liquid catalyst 1, 4-diazabicyclo [2.2.2] in that order]Adding octane acetate into 10ml of dry round-bottom flask, adding 1ml of THF as solvent, heating and stirring at 50 ℃ for reaction for 30min, adding 1.0mmol (0.084g) of 1-penten-3-one, stirring at 50 ℃ for reaction, monitoring the stirring reaction time (3h) by TLC, after the reaction is finished, adding 10ml of water, cooling, adding 10ml of ethyl acetate for extraction for 3 times, drying an organic phase with anhydrous sodium sulfate, filtering and distilling off, separating and purifying a crude product by column chromatography, and adopting petroleum ether and ethyl acetate as eluents (according to volume)The ratio of petroleum ether to ethyl acetate is 3:1 in parts by weight, and pure derivatives (molecular formula C) containing beta-cyanophosphonate are obtained after evaporation, eluent removal and drying17H23N2O4PS)0.275g, purity greater than 98%, reaction yield 72%.
1H NMR(400MHz,CDCl3):δ=1.09(t,J=7.8Hz,3H,CH3),1.22(t,J=7.2Hz,3H,CH3),1.37(t,J=7.2Hz,3H,CH3),2.32-2.39(m,1H,CH2),2.48-2.56(m,3H,CH2),2.85(t,J=7.8Hz,2H,CH2),3.79(s,0.5H,CH),3.84(s,0.5H,CH),3.89-3.98(m,1H,CH2),4.11-4.26(m,3H,CH2),7.10(t,J=4.0Hz,1H,ArH),7.40(t,J=5.2Hz,2H,ArH).
13C NMR(100MHz,CDCl3):δ=7.7,16.2,31.4,36.1,38.1,39.8,44.2,45.6,63.6,63.7,64.6,113.8,114.0,127.5,127.8,130.2,207.3.
31P NMR(162MHz,CDCl3):δ=16.29.
The invention has been described in an illustrative manner, and it is to be understood that any simple variations, modifications or other equivalent changes which can be made by one skilled in the art without departing from the spirit of the invention fall within the scope of the invention.

Claims (8)

1. A synthetic method of a derivative containing beta-cyanophosphonate is characterized by comprising the following steps: stirring a reactant, malononitrile, phosphite ester, an ketene compound, an ionic liquid catalyst and a solvent for reaction, extracting, drying, filtering, evaporating and separating by a chromatographic column to obtain the derivative containing beta-cyanophosphonate, wherein the ratio of the reactant, the malononitrile, the phosphite ester, the ketene compound and the ionic liquid catalyst is (1) - (1.5): (1-1.5): (1-1.5): (0.1-0.2), wherein the ionic liquid catalyst is 1, 4-diazabicyclo [2.2.2]Octane acetate, 1, 4-diazabicyclo [2.2.2]Octane bromate, 1, 4-diazabicyclo [2.2.2]Hydrogen octanesulfate, 1, 4-diazabicyclo [2.2.2]Octane hydrochloride or 1, 4-bisAzabicyclo [2.2.2]Octane tetrafluoroborate, the reactant is
Figure FDA0003630221010000011
Wherein, R is1Is CH3CN or Br, the phosphite ester is
Figure FDA0003630221010000012
Wherein, R is2The ketene compound is 1-pentene-3-ketone, and the beta-cyano phosphonate ester derivative has the following structures:
Figure FDA0003630221010000013
R1is CH3CN or Br, R2Me, Et or Ph.
2. The synthesis method according to claim 1, wherein the solvent is one or more of toluene, ethanol, n-hexane, tetrahydrofuran and methanol.
3. The synthesis method according to claim 1, wherein the stirring reaction is a reaction at 20-60 ℃.
4. The synthesis process according to claim 1, characterized in that the ratio of the parts by mass of the reactants to the parts by volume of the solvent is 1: (0.5-1), wherein the unit of the parts by weight of the substances is mmol, and the unit of the parts by volume is mL.
5. The method of claim 1, wherein the time for the stirring reaction to proceed is determined by thin layer chromatography.
6. The method of claim 1, wherein the stirring is for a reaction time of at least 20 min.
7. The synthesis method according to claim 1, wherein the reactants, the malononitrile, the phosphite ester, the ionic liquid catalyst and the solvent are stirred at 40-50 ℃ for 30-60 min, and then the ketene compound is added for the stirring reaction.
8. The synthesis method of claim 1, wherein the extraction is washing by adding water and ethyl acetate; the drying adopts anhydrous sodium sulfate; an eluent of the chromatographic reaction is a mixture of petroleum ether and ethyl acetate, and the ratio of the petroleum ether to the ethyl acetate is (1-3): 1 in parts by volume.
CN202110357640.8A 2021-04-01 2021-04-01 Synthesis method of beta-cyanophosphonate derivative Expired - Fee Related CN113816993B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110357640.8A CN113816993B (en) 2021-04-01 2021-04-01 Synthesis method of beta-cyanophosphonate derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110357640.8A CN113816993B (en) 2021-04-01 2021-04-01 Synthesis method of beta-cyanophosphonate derivative

Publications (2)

Publication Number Publication Date
CN113816993A CN113816993A (en) 2021-12-21
CN113816993B true CN113816993B (en) 2022-06-07

Family

ID=78912407

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110357640.8A Expired - Fee Related CN113816993B (en) 2021-04-01 2021-04-01 Synthesis method of beta-cyanophosphonate derivative

Country Status (1)

Country Link
CN (1) CN113816993B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116102734B (en) * 2022-12-29 2023-10-24 广州硅碳新材料有限公司 Phosphorus-nitrogen-containing cage polysilsesquioxane, preparation method thereof and application thereof as crusting and carbonizing agent

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102180825A (en) * 2011-03-29 2011-09-14 苏州大学 Method for preparing 3-indole arylmethanesulfonamide
CN111484441A (en) * 2019-01-29 2020-08-04 天津师范大学 Indole triarylmethane derivative and synthetic method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102180825A (en) * 2011-03-29 2011-09-14 苏州大学 Method for preparing 3-indole arylmethanesulfonamide
CN111484441A (en) * 2019-01-29 2020-08-04 天津师范大学 Indole triarylmethane derivative and synthetic method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Four-Component Reactions for the Synthesis of Perfluoroalkyl Isoxazoles;Yuanjin Chen等;《ACS Catal.》;20190905;第9卷(第10期);9098-9102 *

Also Published As

Publication number Publication date
CN113816993A (en) 2021-12-21

Similar Documents

Publication Publication Date Title
CN101157655A (en) Method for synthesizing (4S,5R)- half-ester
CN113816993B (en) Synthesis method of beta-cyanophosphonate derivative
CN104402718B (en) A kind of chiral allyl ester type compound and preparation method thereof
Kupai et al. Preparation of pyridino-crown ether-based new chiral stationary phases and preliminary studies on their enantiomer separating ability for chiral protonated primary aralkylamines
CN113185465B (en) Preparation method of 4-ethyl-5-aminopyrimidine
CN108892601B (en) Preparation method of polycyclic aromatic hydrocarbon with benzofluorene structure
CN115108937B (en) Synthesis method of alpha-azido ketone containing three-level stereo center
CN109232650B (en) Chiral 1-phospha norbornadiene derivative and synthesis method thereof
CN108299297A (en) A kind of novel 6- alkyl phenanthridines and derivative and preparation method thereof
CN113444040A (en) Method for synthesizing chiral alpha-unnatural amino acid derivative under drive of visible light
CN111320664B (en) Preparation method of 24-cholenenoic acid ethyl ester
CN110317170B (en) Green synthesis method of 3-phenanthridinyl propyl formate compound
CN113816994B (en) Synthesis method of (1, 1-dicyano-4-oxy) -hexyl-3-oxoindole diethyl phosphinate and derivatives thereof
CN103373948B (en) Preparation method for natural product (-)-kainic acid
CN111793017A (en) Preparation method of lactam compound
CN111777479A (en) Catalytic asymmetric synthesis method of chiral nitrogen-containing heteroaromatic ring compound
CN110668960A (en) Preparation method of alpha-aryl alpha-aminoketone compound
CN114957305B (en) Automatic synthesis method of mobile phase of anticancer drug Talabostat
CN113861093B (en) Synthesis method of polysubstituted gamma-butyrolactam
CN109810141B (en) Sulfur-containing phosphoramidite ester, preparation method and application thereof
CN108129479B (en) 5, 6-dihydrobenzo [ f ] indolo [2,3-b ] quinoline compound and synthetic method thereof
CN115819267A (en) Etomidate intermediate product and preparation method and application thereof
CN113874371B (en) Preparation method of tri-fused ring compound and intermediate thereof
CN113603606A (en) Preparation method of oseltamivir phosphate dry suspension impurity
CN117756804A (en) A process for preparing a pharmaceutical intermediate pyrido [2,3-d: process for 5,6-d' ] bipyrimidine derivatives

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20220607